1. Home
  2. VNCE vs ATOS Comparison

VNCE vs ATOS Comparison

Compare VNCE & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$4.83

Market Cap

30.9M

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$5.52

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
ATOS
Founded
2002
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
36.2M
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
VNCE
ATOS
Price
$4.83
$5.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.17
$23.00
AVG Volume (30 Days)
245.2K
51.8K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
132.45
N/A
EPS
0.49
N/A
Revenue
$300,007,000.00
$1,758.00
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.48
N/A
Revenue Growth
2.23
N/A
52 Week Low
$1.19
$0.53
52 Week High
$5.28
$7.56

Technical Indicators

Market Signals
Indicator
VNCE
ATOS
Relative Strength Index (RSI) 74.74 53.42
Support Level $2.41 $0.66
Resistance Level N/A $5.56
Average True Range (ATR) 0.48 0.34
MACD 0.20 -0.04
Stochastic Oscillator 85.34 50.97

Price Performance

Historical Comparison
VNCE
ATOS

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: